Blood-based and multimodal tools for earlier disease detection and risk assessment.
Moving laboratory discoveries toward clinical testing, implementation, and patient impact.
Defining molecular pathways that drive disease initiation, progression, and treatment response.
Preclinical models for studying disease biology and evaluating therapeutic strategies.
Manufacturing support for biologics, extracellular vesicles, and investigational therapeutics.
Scientific and regulatory writing support for research programs and submissions.
Clear, compliant protocols for clinical, translational, and preclinical research studies.
Grant development support from concept through submission.
IRB submissions, compliance strategy, regulatory documentation, and study start-up support.
